Subtype
Nasopharyngeal Carcinoma
CI-CAN-00008100NPCExplore in graph →
246 active trials1 approved drugs
- NCIt
- C3871
- OncoTree
- NPC
- UMLS CUI
- C2931822
- MeSH
- D000077274
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00008100NPCExplore in graph →
Clinical trials
702 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (35)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02123511 | Acetylcysteine Rinse in Reducing Saliva Thickness and Mucositis in Patients With Head and Neck Cancer Undergoing Radiation Therapy | completed | Phase 2 | 34 | Mayo ClinicOTHER | 1 | Apr 30, 2019 | clinicaltrials |
| NCT03932266 | Endostar Combined With Induction Chemotherapy and Concurrent Chemoradiotherapy for Locoregional Nasopharyngeal Carcinoma | unknown | Phase 2 | 73 | Jiangsu Cancer Institute & HospitalOTHER | 0 | Apr 30, 2019 | clinicaltrials |
| NCT02012062 | Concurrent Nimotuzumab Versus Cisplatin With Radiotherapy for Locoregionally Advanced NPC | completed | Phase 3 | 160 | Fudan UniversityOTHER | 1 | Apr 10, 2019 | clinicaltrials |
| NCT03876574 | Hepatic Artery Infusion Pump for NPC Liver Metastases | completed | Phase 1 | 16 | Xiangya Hospital of Central South UniversityOTHER | 0 | Mar 15, 2019 | clinicaltrials |
| NCT00535795 | Phase III: Assess Conventional RT w/ Conventional Plus Accelerated Boost RT in the Treatment of Nasopharyngeal CA | completed | Phase 3 | 200 | King Faisal Specialist Hospital & Research CenterOTHER | 1 | Mar 1, 2019 | clinicaltrials |
| NCT03839602 | Delineation of Reducing Clinical Target Volume for Early-stage Nasopharyngeal Carcinoma Patients | completed | Phase 2 | 103 | Sun Yat-sen UniversityOTHER | 1 | Feb 15, 2019 | clinicaltrials |
| NCT03283293 | Target Volume Delineation After NACT in LA-NPCarcinoma Patients Treated With NACT+ CCRT | completed | Phase 2 | 112 | Sun Yat-sen UniversityOTHER | 1 | Feb 12, 2019 | clinicaltrials |
| NCT00484601 | Ifosfamide and Doxorubicin in Patients With Refractory Nasopharyngeal Carcinoma | terminated | Phase 2 | 9 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Feb 11, 2019 | clinicaltrials |
| NCT03049358 | Olfactory Training in Improving Sense of Smell After Radiation Therapy in Patients With Paranasal Sinus or Nasopharyngeal Cancer | terminated | N/A | 15 | Stanford UniversityOTHER | 1 | Feb 5, 2019 | clinicaltrials |
| NCT03601975 | Gemcitabine and Cisplatin With/Without Anlotinib in Advanced Nasopharyngeal Carcinoma | unknown | Phase 3 | 336 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd.INDUSTRY | 1 | Feb 4, 2019 | clinicaltrials |
| NCT02388932 | Stereotactic Body Radiation Therapy in Treating Patients With High Risk Locally Advanced Head and Neck Cancer | terminated | N/A | 3 | Case Comprehensive Cancer CenterOTHER | 1 | Jan 24, 2019 | clinicaltrials |
| NCT01392235 | Famitinib in Treating Patients With Recurrent and/or Metastatic Nasopharyngeal Carcinoma (NPC) | completed | Phase 2 | 58 | Jiangsu HengRui Medicine Co., Ltd.INDUSTRY | 1 | Jan 22, 2019 | clinicaltrials |
| NCT03810274 | 3DV+TPS Software Outlines the Radiotherapy of Nasopharyngeal Carcinoma | completed | — | 300 | Xinqiao Hospital of ChongqingOTHER | 1 | Jan 18, 2019 | clinicaltrials |
| NCT01621880 | Effect of Bevacizumab on Radiation-induced Brain Necrosis in Patients With Nasopharyngeal Carcinoma(BRAIN) | completed | Phase 2 | 112 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Jan 9, 2019 | clinicaltrials |
| NCT03557112 | By Comparing TPF Induction Chemotherapy Combined With Nimotuzumab Concurrent Radiotherapy and Cisplatin Concurrent Radio-chemotherapy for Locally Advanced NPC | unknown | Phase 2 | 180 | Guiyang Medical UniversityOTHER | 1 | Nov 2, 2018 | clinicaltrials |
| NCT03723343 | GP-induced Chemotherapy Combined With IMRT and TPF-induced Chemotherapy Combined With IMRT in the Treatment of Distant Metastatic Nasopharyngeal Carcinoma | unknown | — | 146 | Guiyang Medical UniversityOTHER | 1 | Oct 29, 2018 | clinicaltrials |
| NCT03701451 | Demethylated Drug in the Treatment of Nasopharyngeal Carcinoma | unknown | Phase 1 / Phase 2 | 30 | Wei JiangOTHER | 1 | Oct 10, 2018 | clinicaltrials |
| NCT03639467 | Study of Anlotinib Combined With Gemcitabine/Cisplatin in Advanced Nasopharyngeal Carcinoma | unknown | Phase 1 / Phase 2 | 40 | Chinese Academy of Medical SciencesOTHER | 1 | Sep 18, 2018 | clinicaltrials |
| NCT03666221 | Nimotuzumab for Recurrent Nasopharyngeal Carcinoma | unknown | Phase 2 | 67 | Fujian Cancer HospitalOTHER_GOV | 1 | Sep 11, 2018 | clinicaltrials |
| NCT03657017 | PET/MR in Locally Advanced Nasopharyngeal Carcinoma | unknown | N/A | 150 | Zhejiang Cancer HospitalOTHER | 1 | Sep 4, 2018 | clinicaltrials |
| NCT03647527 | Predictor Analysis of Acute Radiation Oral Mucositis in NPC Patients Treated With IMRT/TOMO Combined Chemotherapy | unknown | — | 200 | Zhejiang Cancer HospitalOTHER | 1 | Aug 27, 2018 | clinicaltrials |
| NCT03612219 | Adjuvant Treatment of Apatinib in Nasopharyngeal Carcinoma | unknown | Phase 2 | 240 | Wei JiangOTHER | 1 | Aug 2, 2018 | clinicaltrials |
| NCT03578575 | To Investigate the Molecular Mechanism of Traditional Chinese Medicine Constitution Using Next-generation Sequencing in Nasopharyngeal Carcinoma | unknown | Phase 2 | 120 | China Medical University HospitalOTHER | 1 | Jul 30, 2018 | clinicaltrials |
| NCT03604965 | GP Induction Chemotherapy us TPF Adjuvant Chemotherapy Combined With DDP Concurrent Chemoradiotherapy in the Treatment of Locally Advanced NPC | unknown | Phase 3 | 204 | Guiyang Medical UniversityOTHER | 1 | Jul 30, 2018 | clinicaltrials |
| NCT03588403 | TOMO Versus IMRT in Nasopharyngeal Carcinoma Patients | unknown | — | 110 | Zhejiang Cancer HospitalOTHER | 1 | Jul 20, 2018 | clinicaltrials |
| NCT03574324 | TPF Induction Chemotherapy vs PF Adjuvant Chemotherapy Combined With Concurrent Chemoradiotherapy in the Treatment of Locally Advanced NPC | unknown | Phase 3 | 266 | Guiyang Medical UniversityOTHER | 1 | Jul 2, 2018 | clinicaltrials |
| NCT03568032 | Radiation-associated Carotid Artery Disease in Patients With Nasopharyngeal Carcinoma | unknown | — | 248 | Fudan UniversityOTHER | 1 | Jun 26, 2018 | clinicaltrials |
| NCT03529279 | CNG Staging Compared With 8th UICC of NPC for Treatment Decision-marking and Selection of Chemotherapy and Radiotherapy | unknown | Phase 3 | 1,324 | Sun Yat-sen UniversityOTHER | 0 | May 18, 2018 | clinicaltrials |
| NCT02434614 | Induction Chemotherapy Followed by IMRT With or Without Concurrent Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma | unknown | Phase 3 | 440 | Wei JiangOTHER | 1 | May 16, 2018 | clinicaltrials |
| NCT03130270 | Maintenance Treatment of Apatinib in Nasopharyngeal Carcinoma | unknown | Phase 2 | 29 | Guilin Medical University, ChinaOTHER | 1 | May 16, 2018 | clinicaltrials |
| NCT03503136 | Nedaplatin Versus Cisplatin and Capecitabine Versus Fluorouracil in IC + CCRT for Locoregionally Advanced NPC(NX-NPC) | unknown | Phase 3 | 632 | Sun Yat-sen UniversityOTHER | 1 | May 11, 2018 | clinicaltrials |
| NCT01341834 | Safety and Tolerability Study of RAD001 and LBH589 in All Solid Tumors With Enrichment for EBV Driven Tumors | unknown | Phase 1 | 49 | National Cancer Centre, SingaporeOTHER | 1 | Apr 24, 2018 | clinicaltrials |
| NCT01872962 | Induction Gemcitabine and Cisplatin in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma | unknown | Phase 3 | 480 | Sun Yat-sen UniversityOTHER | 1 | Apr 24, 2018 | clinicaltrials |
| NCT01462474 | Concurrent Chemoradiotherapy With Famitinib for Patients With Locally Advanced Nasopharyngeal Carcinoma(FMTN-I-LNPC) | completed | Phase 1 | 20 | Jiangsu HengRui Medicine Co., Ltd.INDUSTRY | 1 | Apr 18, 2018 | clinicaltrials |
| NCT01534585 | Safety and Efficacy Study of Icotinib With Intensity-modulated Radiotherapy in Nasopharyngeal Carcinoma | completed | Phase 1 / Phase 2 | 48 | Taizhou HospitalOTHER | 1 | Apr 17, 2018 | clinicaltrials |
| NCT02776124 | Effect of Oral Supplements on the Nutritional Status of Locally Advanced Nasopharyngeal Carcinoma Patients | completed | Phase 2 | 60 | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong UniversityOTHER | 1 | Mar 19, 2018 | clinicaltrials |
| NCT03427359 | Induction Cisplatin and Capecitabine Followed by Concurrent Chemoradiotherapy for Nasopharyngeal Carcinoma | completed | Phase 2 | 65 | The University of Hong Kong-Shenzhen HospitalOTHER | 0 | Feb 9, 2018 | clinicaltrials |
| NCT03202173 | The Diagnosis of NPC Using the Probe-based Confocal Laser Endomicroscopy | unknown | N/A | 31 | Eye & ENT Hospital of Fudan UniversityOTHER | 1 | Feb 5, 2018 | clinicaltrials |
| NCT00408694 | Bevacizumab, Cisplatin, Radiation Therapy, and Fluorouracil in Treating Patients With Stage IIB, Stage III, Stage IVA, or Stage IVB Nasopharyngeal Cancer | completed | Phase 2 | 46 | National Cancer Institute (NCI)NIH | 2 | Jan 30, 2018 | clinicaltrials |
| NCT03411954 | Hippocampus Avoidance During Intensity Modulated Radiotherapy for T4 Nasopharyngeal Carcinoma Patients | unknown | — | 100 | Zhejiang Cancer HospitalOTHER | 1 | Jan 26, 2018 | clinicaltrials |
| NCT03398980 | Late Sequelae of Childhood and Adolescent Nasopharyngeal Carcinoma Survivors After Radiotherapy | completed | — | 94 | Yuan-hong GaoOTHER | 0 | Jan 16, 2018 | clinicaltrials |
| NCT02590133 | A Phase II Clinical Trial of Chemotherapy With or Without Endostar® Continuous Intravenous Infusion in Refractory NPC | unknown | Phase 2 | 328 | Yun-fei XiaOTHER | 1 | Dec 22, 2017 | clinicaltrials |
| NCT03344068 | Early and Whole Course Nutritional Support by Nutren® Optimum During IMRT for Nasopharyngeal Carcinoma | unknown | Phase 2 / Phase 3 | 408 | Sun Yat-sen UniversityOTHER | 1 | Dec 22, 2017 | clinicaltrials |
| NCT02584790 | NBI to Detect Post-RT Mucosal Residual NPC | completed | N/A | 55 | Pamela Youde Nethersole Eastern HospitalOTHER | 1 | Dec 8, 2017 | clinicaltrials |
| NCT02022293 | Atorvastatin in Preventing Nasopharyngeal Carcinoma Patients Receiving Radiotherapy From Carotid Stenosis | suspended | Phase 2 | 324 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Dec 4, 2017 | clinicaltrials |
| NCT03045484 | Comparison of Oxycodone to Control Moderate or Severe Oral Mucositis Pain Induced by Chemoradiotherapy | unknown | N/A | 70 | Sun Yat-sen UniversityOTHER | 1 | Nov 29, 2017 | clinicaltrials |
| NCT03290001 | The Influence of Anxiety and Depression on Survival in Nasopharyngeal Carcinoma Patients | unknown | — | 1,000 | Sun Yat-sen UniversityOTHER | 1 | Nov 7, 2017 | clinicaltrials |
| NCT03290820 | Aspirin Improve Survival of N2-3 Nasopharyngeal Carcinoma Patients | unknown | Phase 2 | 184 | Sun Yat-sen UniversityOTHER | 1 | Oct 26, 2017 | clinicaltrials |
| NCT03314051 | Long-term Treatment Outcome for Stage III NPC Patients and Risk Grouping by Plasma EBV DNA | completed | — | 366 | Taichung Veterans General HospitalOTHER | 0 | Oct 20, 2017 | clinicaltrials |
| NCT00953420 | Carboplatin and Docetaxel Followed by Epstein-Barr Virus Cytotoxic T Lymphocytes(CADEN) | completed | Phase 2 | 20 | Baylor College of MedicineOTHER | 1 | Aug 18, 2017 | clinicaltrials |
Data updated 23 days agoSource updated Apr 30, 2019source: clinicaltrials